Read the full story from the Product Stewardship Institute.
The U.S. Supreme Court denied certiorari in a case brought by the Pharmaceutical Research and Manufacturers of America (PhRMA) and two other industry trade groups, which challenged the constitutionality of Alameda County, California’s drug disposal law. The ordinance – the first of its kind – requires drug manufacturers to fund and manage the safe disposal of unwanted medications. The Supreme Court decision means that the Alameda ordinance, as well as similar laws passed in San Francisco, California,San Mateo, California, and King County, Washington, will stand.
The Supreme Court’s decision not to hear the challenge brought by PhRMA, the Generic Pharmaceutical Association, and the Biotechnology Industry Organization will pave the way for more extended producer responsibility (EPR) laws, which hold manufacturers responsible for the end-of-life management of their products. By taking accountability for these items once consumers are done with them, producers can help protect both communities and the environment.